Security key
52490G102
- Security type / class
- Equity / COMMON STOCK
- Total 13F shares
- 96,070,629
- Total 13F value
- $1,737,725,576
- Share change
- +8,465,922
- Put/Call ratio
- 72%
- SEC-reported price per share
- $18.09
- Number of holders
- 191
- Value change
- +$133,064,401
- Number of buys
- 109
- Number of sells
- 88
- Shares outstanding
- 386,641,322
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2026
Institutions
191
Top holders
10
LEGN full security history
Ownership snapshot
Full 13F holder table
Legend Biotech Corp SEC filings
Legend Biotech Corp company facts
Broader feeds
Ownership snapshot
Top reported holders of LEGN - Legend Biotech Corp - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
PRICE T ROWE ASSOCIATES I...
Disclosed value leader
FMR LLC
Comparable rows
15/15
Latest evidence
18 Mar 2026
13D/G
3/4/5
13F
Lead comparable stake: 3.7%
13D/G row: PRICE T ROWE ASSOCIATES INC /MD/
Showing 1-6 of 15 holder rows.
Quick read
PRICE T ROWE ASSOCIATES INC /MD/ leads the comparable SEC ownership view at 3.7%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens PRICE T ROWE ASSOCIATES INC /MD/'s linked filing trail.
Comparable ownership
Top 5
PRICE T ROWE ASSOCIATES INC /MD/
3.7%
Darren Xiaohui Ji
0.02%
Corazon (corsee) D. Sanders
0.02%
Li Mao
0.01%
Tomas J. Heyman
0.01%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| PRICE T ROWE ASSOCIATES INC /MD/ |
13D/G
T. Rowe Price Associates, Inc.
|
3.7%
|
$233,379,028
6,808,023 shares
|
$0 | 31 Dec 2024 |
| Darren Xiaohui Ji |
3/4/5
Director
|
0.02%
|
$1,259,516
63,773 shares
|
— | 18 Mar 2026 |
| Corazon (corsee) D. Sanders |
3/4/5
Director
|
0.02%
|
$1,167,521
59,115 shares
|
— | 18 Mar 2026 |
| Li Mao |
3/4/5
Director
|
0.01%
|
$875,517
44,330 shares
|
— | 18 Mar 2026 |
| Tomas J. Heyman |
3/4/5
Director
|
0.01%
|
$646,496
32,734 shares
|
— | 18 Mar 2026 |
| Gareth Kung |
3/4/5
Director
|
0.01%
|
$621,848
31,486 shares
|
— | 18 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
191
Shares
96,070,629
Rows available
191
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2026 vs Q1 2026 Across Filers
Q1 2026 holders
191
Q1 2026 holders
191
Holder diff
0
| Investor | Q1 2026 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q1 2026 value | Value change | Value Chg % |
|---|